January 4, 2022

PacBio to Present at Upcoming Investor Conference

MENLO PARK, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) — PacBio announced today that its executives will be speaking virtually at the following investor conference:

  • 40th Annual J.P. Morgan Healthcare Conference on January 13, 2022, at 12:00 pm Eastern Time (9:00 am Pacific Time)

The live webcast can be accessed at the company’s investors page at . A replay of the webcast will be available for at least 30 days following the presentation.

About PacBio

Pacific Biosciences of California, Inc. (NASDAQ: PACB) is empowering life scientists with highly accurate long-read sequencing. The company’s innovative instruments are based on Single Molecule, Real-Time (SMRT®) Sequencing technology, which delivers a comprehensive view of genomes, transcriptomes, and epigenomes, enabling access to the full spectrum of genetic variation in any organism. Cited in thousands of peer-reviewed publications, PacBio® sequencing systems are in use by scientists around the world to drive discovery in human biomedical research, plant and animal sciences, and microbiology. For more information please visit and follow @PacBio.


Todd Friedman

Kathy Lynch

Talk with an expert

If you have a question, need to check the status of an order, or are interested in purchasing an instrument, we're here to help.